Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Adult Langerhans Cell Histiocytosis with Liver Involvement

Long Chang, Lin He, Huacong Cai, Minghui Duan, Jian Li, Daobin Zhou, Gaurav Goyal, Xinxin Cao

Blood (2023) 142 (Supplement 1): 3197.

https://doi.org/10.1182/blood-2023-184790

Published: 2023

Journal Articles

Outcomes with MEK Inhibitor Therapy Among Adults with Langerhans Cell Histiocytosis (LCH): A Multi-Institutional Study from the Adult LCH Working Group for the Histiocyte Society

Blood (2023) 142 (Supplement 1): 4559.

https://doi.org/10.1182/blood-2023-184911

Published: 2023

Journal Articles

Clinical Characteristics, Genomic Profiling and Outcomes of Langerhans Cell Histiocytosis in Adults with Single System Multifocal Disease

Hong-Xiao Han, Long Chang, Min Lang, Lin He, Jian Li, Minghui Duan, Daobin Zhou, Xinxin Cao, Wen Gao

Blood (2023) 142 (Supplement 1): 1165.

https://doi.org/10.1182/blood-2023-178177

Published: 2023

Journal Articles

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

Blood (2023) 142 (Supplement 1): 3039.

https://doi.org/10.1182/blood-2023-181500

Published: 2023

Journal Articles

Lenalidomide and Dexamethasone for Patients with Rosai-Dorfman Disease: A Single Arm, Single Center, Prospective Phase 2 Study

Long Chang, Lin He, Jian Li, Daobin Zhou, Xinxin Cao, Wen Gao

Blood (2023) 142 (Supplement 1): 6331.

https://doi.org/10.1182/blood-2023-184621

Published: 2023

Journal Articles

Efficacy and Safety of Peginterferon Alfa-2b in 95 Patients with Myeloproliferative Neoplasms:a Single Center Retrospective Analysis

Long Chang, Hao Cai, Xinxin Cao, Jian Li, Daobin Zhou, Minghui Duan

Blood (2022) 140 (Supplement 1): 12244.

https://doi.org/10.1182/blood-2022-168360

Published: 2022

Journal Articles

Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes

Blood (2022) 140 (Supplement 1): 9289–9291.

https://doi.org/10.1182/blood-2022-157311

Published: 2022

Journal Articles

Rituximab and Bortezomib for Patients with Newly Diagnosed Acquired Haemophilia: Single Arm, Single Center, Prospective Phase 2 Study

Huacong Cai, Xinxin Cao, Shujie Wang, Yongqiang Zhao, Jian Li, Tie-nan Zhu

Blood (2022) 140 (Supplement 1): 2715–2716.

https://doi.org/10.1182/blood-2022-166513

Published: 2022

Journal Articles

A Prospective Study of Bortezomib, Cyclophosphamide and Dexamethasone in Newly-Diagnosed Idiopathic Multicentric Castleman's Disease

Hao Zhao, Miaoyan Zhang, Yanying Yu, Xinxin Cao, Dao-Bin Zhou, Lu Zhang, Jian Li

Blood (2022) 140 (Supplement 1): 4442–4443.

https://doi.org/10.1182/blood-2022-166349

Published: 2022

Journal Articles

Efficacy and Safety of Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Patients with Mayo 2004 Stage 3 Light-Chain Amyloidosis: A Prospective Phase 2 Study

Ya-Juan Gao, Kaini Shen, Long Chang, Jun Feng, Yueying Mao, Lu Zhang, Xinxin Cao, Daobin Zhou, Jian Li

Blood (2022) 140 (Supplement 1): 4391–4392.

https://doi.org/10.1182/blood-2022-157044

Published: 2022

Journal Articles

Maintenance Therapy with Single-Agent Lenalidomide for POEMS Syndrome

Yanying Yu, Xuemin Gao, Hao Zhao, Anan Li, Hao Cai, Jun Feng, Lu Zhang, Xinxin Cao, Jian Li

Blood (2022) 140 (Supplement 1): 10118–10119.

https://doi.org/10.1182/blood-2022-158642

Published: 2022

Journal Articles

Phase Ib/II Study of Rituximab, Lenalidomide and Methotrexate Followed By Lenalidomide Maintenance in Patients with Newly Diagnosed Primary CNS Lymphoma: The Remla Trial

Yan Zhang, Wei Wang, Jian Li, Daobin Zhou, Wei Zhang, Danqing Zhao, Chong Wei, Lu Zhang, Xinxin Cao

Blood (2022) 140 (Supplement 1): 6608–6609.

https://doi.org/10.1182/blood-2022-165934

Published: 2022

Journal Articles

The Interim Analysis from a Prospective Single-Center Phase 2 Study of Zanubrutinib Plus R-CHOP in Treat-Naïve Intravascular Large B Cell Lymphoma

Yan Zhang, Congwei Jia, Wei Wang, Lu Zhang, Xinxin Cao, Jian Li, Wei Zhang, Daobin Zhou

Blood (2021) 138 (Supplement 1): 3563.

https://doi.org/10.1182/blood-2021-152417

Published: 2021

Journal Articles

A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results

Junyuan Qi, MD, Jian Li, MD, Bin Jiang, MD, Bo Jiang, MD, Hongzhong Liu, MD, Xinxin Cao, MD, Meixiang Zhang, MD, Yuan Meng, MD, Xiaoyu MA, Yingmin Jia, Jiyuan Guo, Yanni Zhang, Wei Huang, Jianxiang Wang, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-134391

Published: 2020

Journal Articles

Unicentric Castleman Disease with High Inflammatory State: Surgical Treatment Is a Potential Cure

Miaoyan Zhang, Xinxin Cao, MD, Dao-Bin Zhou, Lu Zhang, MD, Jian Li, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-134350

Published: 2020

Journal Articles

Treatment Outcome and Prognostic Factors for Adult Langerhans Cell Histiocytosis

Xinxin Cao, MD, Ming-hui Duan, MD, Ai-lin Zhao, Hao Cai, Jia Chen, Xue-min Gao, Ting Liu, Hua-cong Cai, MD, Lu Zhang, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Jian Li, MD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-138426

Published: 2020

Journal Articles

Impact of Hematologists' Personality and Behavioral Traits on Medical Decision-Making for Elderly Acute Myeloid Leukemia: A National Study in China

Xia Wu, MD, Yi-Nan Jiang, Yue-Lun Zhang, Jia Chen, Yue-ying Mao, Lu Zhang, MD, Dao-Bin Zhou, Xinxin Cao, MD, Jian Li, MD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-135957

Published: 2020

Journal Articles

Doxycycline Combined with Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Patients with Mayo 2004 Stage II-III Light-Chain Amyloidosis: A Randomized Controlled Multicenter Study

Kaini Shen, MD, Yujun Dong, MD, Weijun Fu, Sr., MD PhD, Yu Wu, MD, Zhongxia Huang, Yongqiang Wei, PhD, Chunrui Li, MD PhD, Chunyan Sun, MD PhD, Wenrong Huang, Huihan Wang, MD PhD, Congli Zhang, Huilei Miao, Lu Zhang, MD, Xinxin Cao, MD, Daobin Zhou, MD, Jian Li, MD

Blood (2019) 134 (Supplement_1): 1870.

https://doi.org/10.1182/blood-2019-122087

Published: 2019

Journal Articles

Characteristics of Serum Lipidome in Patients with POEMS Syndrome

Hao Zhao, MD, Xue-min Gao, Xinxin Cao, MD, Lu Zhang, MD, Dao-Bin Zhou, Jian Li, MD

Blood (2019) 134 (Supplement_1): 3082.

https://doi.org/10.1182/blood-2019-122239

Published: 2019

Journal Articles

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Xinxin Cao, Jian Li, MD, Ai-lin Zhao, Xue-min Gao, Hua-cong Cai, MD, Lu Zhang, MD, Yan Zhang, MD, Jun Feng, MD, Miao Chen, MD, Tie-nan Zhu, MD, Na Niu, Jian Sun, MD, Zhi-yong Liang, MD, Dao-Bin Zhou, Ming-hui Duan, MD

Blood (2019) 134 (Supplement_1): 294.

https://doi.org/10.1182/blood-2019-122220

Published: 2019

NARROW

Adult Langerhans Cell Histiocytosis with Liver Involvement

Outcomes with MEK Inhibitor Therapy Among Adults with Langerhans Cell Histiocytosis (LCH): A Multi-Institutional Study from the Adult LCH Working Group for the Histiocyte Society

Clinical Characteristics, Genomic Profiling and Outcomes of Langerhans Cell Histiocytosis in Adults with Single System Multifocal Disease

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

Lenalidomide and Dexamethasone for Patients with Rosai-Dorfman Disease: A Single Arm, Single Center, Prospective Phase 2 Study

Efficacy and Safety of Peginterferon Alfa-2b in 95 Patients with Myeloproliferative Neoplasms:a Single Center Retrospective Analysis

Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes

Rituximab and Bortezomib for Patients with Newly Diagnosed Acquired Haemophilia: Single Arm, Single Center, Prospective Phase 2 Study

A Prospective Study of Bortezomib, Cyclophosphamide and Dexamethasone in Newly-Diagnosed Idiopathic Multicentric Castleman's Disease

Efficacy and Safety of Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Patients with Mayo 2004 Stage 3 Light-Chain Amyloidosis: A Prospective Phase 2 Study

Maintenance Therapy with Single-Agent Lenalidomide for POEMS Syndrome

Phase Ib/II Study of Rituximab, Lenalidomide and Methotrexate Followed By Lenalidomide Maintenance in Patients with Newly Diagnosed Primary CNS Lymphoma: The Remla Trial

The Interim Analysis from a Prospective Single-Center Phase 2 Study of Zanubrutinib Plus R-CHOP in Treat-Naïve Intravascular Large B Cell Lymphoma

A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results

Unicentric Castleman Disease with High Inflammatory State: Surgical Treatment Is a Potential Cure

Treatment Outcome and Prognostic Factors for Adult Langerhans Cell Histiocytosis

Impact of Hematologists' Personality and Behavioral Traits on Medical Decision-Making for Elderly Acute Myeloid Leukemia: A National Study in China

Doxycycline Combined with Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Patients with Mayo 2004 Stage II-III Light-Chain Amyloidosis: A Randomized Controlled Multicenter Study

Characteristics of Serum Lipidome in Patients with POEMS Syndrome

Methotrexate and Cytarabine for Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only